All In Biotech

Investigational drug · Phase 3

IO102-IO103

Not approved by FDA. In 3 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Metastatic Melanoma, Unresectable Melanoma, Melanoma.

Phase 3

Last checked: Nov 20, 2026Latest source record: Apr 8, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

3

2 still active

All registered trials

7

Any phase or sponsor naming "IO102-IO103"

First trial start

2022

Apr 11, 2022

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "IO102-IO103", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Metastatic Melanoma
  • Unresectable Melanoma
  • Melanoma
  • Squamous Cell Carcinoma of Head and Neck
  • Lung Cancer Non Small Cell
  • Head and Neck Squamous Cell Carcinoma
  • Urothelial Carcinoma Bladder

Approved drugs for the same conditions: Melanoma · Bladder and urothelial cancer · Head and neck cancer · Oncology · Kidney and urology

Largest trials

Live from ClinicalTrials.gov: studies naming "IO102-IO103" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 3 on PubMed

Also in development for Metastatic Melanoma

  • ONC-392Gotistobart, BNT316Phase 35 trials

    OncoC4, Inc. · Non Small Cell Lung Cancer, Ovarian Cancer, Advanced Solid Tumor

  • RO7247669Tobemstomig, RG6139Phase 26 trials

    Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer

  • IOV-3001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma

  • IOV-4001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer

  • OBX-115Phase 21 trial

    Obsidian Therapeutics, Inc. · Tumor Skin, Metastatic Melanoma, Melanoma

  • ST101Phase 21 trial

    Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.